sitting down with north korean dictator, kim jong-un. aides say outspoken style irritated the president for months. he has strong views, but that s okay. i actually temper john. bolton also found himself at odds with pompeo who s much more willing to tout the president s foreign policy views. there were places we had different views. with bolton out of way, the administration is sounding more open to the idea of the president sitti inting down wit iran s president. the president has made clear he s happy to take a meeting with no precbs, but we are maintaining a maximum pressure campaign. the former national security adviser did say he resigned yesterday and offered his letter of resignation yesterday evening. this is the letter of resignation offered up by the white house today from john bolton. dated september 10th. i hereby resign effective immediately as assistant to the
warning the president that he s out of loopholes. he had to disclose this thing. so he did, but it s terrible that talking about a terrible message, the tone from the top for the other 25,000 people who have to file financial disclosure reports, that he s saying i didn t have to report this. op onthe front coverage page, yes, you did. he knew for a while that the position was reportable and still wrote a note, it s not reportable, but here you go. completely flaunting what they re saying. if they re able to determine, hey, he lied. knew about this last year and it wasn t included. could he face charges? he could. and we get back in that discussion of whether the president is indictable. he could face charges. there could be civil penalties associated with this. but i think it really just fits into a larger narrative.
i mean, let s face it here, these debates can get pretty heated and by the way, if you flew all the way to beijing for the meetings with the chinese then weren t allowed into the meetings, wouldn t you be upset? i would. you ve got this situation where this guy, navarro, who s done thog but 20 years but write about the economic confrontation with china that we re no now and all steve mnuchin is is doing is trying to keep him out of the mite metings. you ve got two wars going on. the economic war between the united states and the people who probably of china and the war inside the trump administration about how to fight the first war. yeah. the president is in the middle. when all these fights, we just keep hearing ab it. josh, you ve been reporting today about the trade talks. that china s given the u.s. a list of demands for the talks and one of them pertains to the technology firm zte that marco rubio said is an espionage throw to the united states.
exercises, their drills. troops are still there. satellites are overhead. everyone in the u.s. military still watching north korea very carefully. if and when there s a deal and there are orders from president trump, they ll adjust. thanks very much. that s it for me. thanks very much for watching. i m wolf blitzer in the situation room. erin burnett outfront starts right now. outfront next, breaking news. trump s attorney says bob mueller s team has concluded they cannot indict a sitting president. if that s true, is trump in the clear? also breaking. michael cohen reportedly trying to sell access to the president. for the president to the government of qatar and wait until you hear the price tag on this one. your jaw is going to drop. we have the breaking details and blow up on trump s teep tonight. his top trade adviser going after the treasury secretary expletive layden. and good evening.
why not tell us. thank you all. and next, a blow up between two key members of trump s team. new information on what it was about plus the president lashing out on reports he s caving the china. the reporter at the center of trump s fury tonight, outfront next. i have type 2 diabetes. i m trying to manage my a1c, then i learn type 2 diabetes puts me at greater risk for heart attack or stroke. can one medicine help treat both blood sugar and cardiovascular risk? i asked my doctor. she told me about non-insulin victoza®. victoza® is not only proven to lower a1c and blood sugar, but for people with type 2 diabetes treating their cardiovascular disease, victoza® is also approved to lower the risk of major cv events such as heart attack,